CDEK
← All drugs Report issue

ro4929097

Small moleculeexperimental

Clinical trial activity

35 trials · 17 clinical orgs · 0 marketing orgs

Phase 1
22
Phase 2
17
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2007 (NCT00532090)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • 2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide
  • rg4733
  • ro4929097
  • ro4929097
  • ro4929097
  • ro 4929097
  • ro-4929097

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01269411Phase 1Jul 1, 2011National Cancer Institute (NCI), University of Toronto
NCT01270438Phase 2Dec 1, 2010Cornell University, National Cancer Institute (NCI)
NCT01122901Phase 2Dec 1, 2010National Cancer Institute (NCI)
NCT01189240Phase 1/Phase 2 (Phase 2)Dec 1, 2010National Cancer Institute (NCI)
NCT01238133Phase 1Dec 1, 2010National Cancer Institute (NCI), Ohio State University
NCT01251172Phase 2Dec 1, 2010National Cancer Institute (NCI), Rutgers University
NCT01208441Phase 1Nov 1, 2010National Cancer Institute (NCI), University of Pittsburgh
NCT01236586Phase 1Oct 8, 2010National Cancer Institute (NCI)
NCT01149356Phase 1Oct 1, 2010National Cancer Institute (NCI), Vanderbilt University
NCT01232829Phase 2Oct 1, 2010National Cancer Institute (NCI), University of Colorado
NCT01120275Phase 2Oct 1, 2010National Cancer Institute (NCI), Southwest Oncology Group
NCT01217411Phase 1/Phase 2 (Phase 2)Oct 1, 2010National Cancer Institute (NCI), University of Texas at Houston
NCT01216787Phase 2Sep 1, 2010National Cancer Institute (NCI), Yeshiva University
NCT01218620Phase 1Sep 1, 2010National Cancer Institute (NCI), University of Wisconsin
NCT01193868Phase 2Sep 1, 2010National Cancer Institute (NCI), University of Texas at Houston
NCT01198535Phase 1Sep 1, 2010National Cancer Institute (NCI), Vanderbilt University
NCT01196416Phase 1/Phase 2 (Phase 2)Aug 1, 2010Cornell University, National Cancer Institute (NCI)
NCT01200810Phase 2Aug 1, 2010National Cancer Institute (NCI), University of Medicine and Dentistry of New Jersey
NCT01192763Phase 1Aug 1, 2010National Cancer Institute (NCI), University of Chicago
NCT01198184Phase 1Aug 1, 2010National Cancer Institute (NCI), University of Toronto
Showing 20 of 35 trials
Page 1 / 2

Organizations

Research & Development (17)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government333322009
University of TorontoAcademic/Hospital8022010
Cornell UniversityAcademic/Hospital4022010
University of Texas at HoustonAcademic/Hospital3022010
RocheFor profit2222007
University of WisconsinAcademic/Hospital2012010
Vanderbilt UniversityAcademic/Hospital2012010
Ohio State UniversityAcademic/Hospital1012010
Rutgers UniversityAcademic/Hospital1012010
Southwest Oncology GroupAcademic/Hospital1012010
University of ChicagoAcademic/Hospital1012010
University of ColoradoAcademic/Hospital1012010
University of Medicine and Dentistry of New JerseyAcademic/Hospital1012010
University of PittsburghAcademic/Hospital1012010
University of South FloridaAcademic/Hospital1012010
Wayne State UniversityAcademic/Hospital1012009
Yeshiva UniversityAcademic/Hospital1012010
17 organizations
Page 1 / 1